This is a preview of subscription content, log in via an institution to check access.
References
Heaney R, Baylink D, Johnston C, Melton LJ, Meunier P, Murray T, Nagant de Deuxchaisnes C (1989) Fluoride therapy for vertebral crush fracture syndrome. A status report. Annal Intern Med 111:678–680
Pak CYC, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K (1989) Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 68:150–159
Mamelle N, Dusan R, Martin JI, Meunier PJ, Gauillaume M, Faucher A, Zeigler G. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis, Lancet 361–365, 1988
Riggs BL, Hodgson SF, Wahner H, Muhs J, O'Fallon WM. Effect of long-term fluoride therapy in bone metabolism, bone density, and fracture rate in Type 1 (postmenopausal) osteoporosis: final results of prospective, controlled, double-blind Clinical Trial. Presented at Joint Meeting of ICCRH and ASBMR, September 13, 1989, Montreal, Canada
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harrison, J.E. Fluoride treatment for osteoporosis. Calcif Tissue Int 46, 287–288 (1990). https://doi.org/10.1007/BF02563816
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02563816